Form 4 for VBIO Valion Bio, Inc.
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-12 · accession 0001104659-21-139507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-12 | VBIO | Ernst Jennifer | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | +28.4K | 1.17M | +2% | $0 |
| DM | 2021-11-15 | 2021-11-12 | VBIO | Ernst Jennifer | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | -5,566 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | C | A | 26,986 | $0.00 | 1,199,877 | D | — | — | (F2) On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. |
| 2 | Common | Common Stock | 2021-11-12 | C | A | 1,391 | $0.00 | 1,172,891 | D | — | — | (F1) The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. |
| 3 | Derivative | Convertible Promissory Note | 2021-11-12 | C | D | — | $0.00 | 0 | D | $3.75 · — to — | 26,986 Common Stock | (F2) On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. (F3) The Note was scheduled to mature on June 1, 2023. |
| 4 | Derivative | Series Seed-2 Convertible Preferred Stock | 2021-11-12 | C | D | 5,566 | $0.00 | 0 | D | — · 2021-03-01 to — | 1,391 Common Stock | (F1) The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. |